Table 1:

Baseline clinical characteristics considered for adjusted analysis

IodixanolLOCMaP Value
Ageb (median) (range) (yr)73 (47–83)68.5 (24–82).07
Baseline glucoseb (mmol/L) (median) (range)6.9 (5.2–18.3)6.6 (3.8–21.5).33
Diabetes (%)19.417.7.83
Baseline SBP (mm Hg)b (median) (range)145.5 (116–185)146 (102–194).82
History of high BP (%)74.273.5.94
Atrial fibrillation (%)48.435.3.19
Coronary artery disease (%)35.519.6.07
ASPECTS 8–10b (%)41.949.0.49
Baseline NIHSSb
    ≥20%35.537.3.86
    ≤19%64.562.8
Historical mRS (No. Sx)b (%)90.386.3.46
Antiplatelet agents (%)67.744.1.02
Presumptive stroke location right (%)51.649.0.80
Baseline CTA/MRA (%)61.351.0.31

  • Note:—Sx indicates symptoms; SBP, systolic blood pressure; BP, blood pressure.

  • ↵a Four LOCM (mOsm/Kg H2O): iohexol (672), iopamidol (616), ioversol (651), iopromide (607).11

  • ↵b Baseline factors relevant to prespecified outcomes.